Department of Medicine,
Robert H. Lurie Cancer Center,
Center for Molecular Innovation and Drug Discovery
Raymond C. Bergan has not added Biography.
If you are Raymond C. Bergan and would like to personalize this page please email our Author Liaison for assistance.
Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion.
Oncogene Nov, 2002 | Pubmed ID: 12447690
Some aspects of analysis of gene array data.
Cancer treatment and research , 2002 | Pubmed ID: 12613351
An analysis of gene array data related to cell adhesion and prostate cancer.
Cancer treatment and research , 2002 | Pubmed ID: 12613352
p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
Oncogene Jul, 2003 | Pubmed ID: 12894225
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Nov, 2003 | Pubmed ID: 14652284
Safety and efficacy of weekly oral oltipraz in chronic smokers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Apr, 2005 | Pubmed ID: 15824161
Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.
Cancer research Apr, 2005 | Pubmed ID: 15833883
Renal medullary carcinoma and ABL gene amplification.
The Journal of urology Jun, 2005 | Pubmed ID: 15879768
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
Cancer Jun, 2006 | Pubmed ID: 16615097
Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Molecular pharmacology Sep, 2006 | Pubmed ID: 16772519
Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.
Molecular pharmacology Jan, 2008 | Pubmed ID: 17951357
Associations of serum carotenoid levels with serum insulin-like growth factor-i and insulin-like growth factor binding protein-3 levels in black men and white men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Dec, 2007 | Pubmed ID: 18086788
The methodology used to measure differential gene expression affects the outcome.
Journal of biomolecular techniques : JBT Dec, 2007 | Pubmed ID: 18166675
Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Molecular carcinogenesis Sep, 2008 | Pubmed ID: 18240292
Dietary genistein inhibits metastasis of human prostate cancer in mice.
Cancer research Mar, 2008 | Pubmed ID: 18339885
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.
Nanomedicine : nanotechnology, biology, and medicine Sep, 2008 | Pubmed ID: 18567541
MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
Journal of the National Cancer Institute Aug, 2009 | Pubmed ID: 19638505
Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.
Carcinogenesis Mar, 2010 | Pubmed ID: 19736306
Inhibition of cancer cell invasion and metastasis by genistein.
Cancer metastasis reviews Sep, 2010 | Pubmed ID: 20730632
Endoglin suppresses human prostate cancer metastasis.
Clinical & experimental metastasis Jan, 2011 | Pubmed ID: 20981476
Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression.
ACS medicinal chemistry letters Nov, 2010 | Pubmed ID: 21116437
Endoglin regulates cancer-stromal cell interactions in prostate tumors.
Cancer research May, 2011 | Pubmed ID: 21444673
The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.
Cancer prevention research (Philadelphia, Pa.) Apr, 2011 | Pubmed ID: 21464034
Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial.
Cancer prevention research (Philadelphia, Pa.) Feb, 2012 | Pubmed ID: 22307566
Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum.
Journal of structural and functional genomics Mar, 2013 | Pubmed ID: 23539270
Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
Cancer research Jun, 2013 | Pubmed ID: 23539448
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.
Oral oncology Sep, 2013 | Pubmed ID: 23845699
Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors.
PloS one , 2013 | Pubmed ID: 23967299
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved